Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

N Ben-Baruch

Showing results (11-20 of 26) with videos related to

Pageof 3
Sort By:
The Journal of Reproductive Medicine|July 1, 1988
Concurrence of ovarian cancer and dermatomyositis. A report of two cases and literature reviewN Mordel, E J Margalioth, N Harats, et al.
International Journal of Oral and Maxillofacial Surgery|June 1, 1990
The use of monoclonal anti-CEA antibody immunohistochemistry in detecting the origin of oral cavity metastasisD W Nitzan, N Livni, Y Marmary, et al.
Investigational New Drugs|February 1, 1993
Phase II study of fazarabine (NSC 281272) in patients with metastatic colon cancerN Ben-Baruch, A M Denicoff, B R Goldspiel, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|October 1, 1990
Radiation therapy for locally advanced breast cancer: prognostic factors and complication rateZ Weshler, G Brufman, A Sulkes, et al.
Journal of Chemotherapy (Florence, Italy)|April 1, 1989
Methylprednisolone and chlorpromazine in patients receiving cancer chemotherapy: a prospective non-randomized studyE Gez, G Brufman, B Kaufman, et al.
Chemioterapia : International Journal of the Mediterranean Society of Chemotherapy|June 1, 1987
Combined immunotherapy and chemotherapy with tuftsin plus cyclophosphamide in the treatment of non-small-cell carcinoma of the lungE Warner, A Sulkes, E Gez, et al.
Cancer Research|February 25, 1990
Phase I and pharmacokinetic study of arabinofuranosyl-5-azacytosine (fazarabine, NSC 281272)A Surbone, H Ford, J A Kelley, et al.
Molecular Pharmacology|July 1, 1994
c-myc Down-regulation in suramin-treated HL60 cells precedes growth inhibition but does not trigger differentiationN Ben-Baruch, W C Reinhold, N Alexandrova, et al.
Oncology|January 1, 1987
High-dose metoclopramide and dexamethasone as an antiemetic in outpatients receiving chemotherapy for breast cancer. Second studyE Gez, E Warner-Efraty, R Ben-Yosef, et al.
European Journal of Cancer & Clinical Oncology|December 1, 1989
Systemic administration of doxorubicin-containing liposomes in cancer patients: a phase I studyA Gabizon, T Peretz, A Sulkes, et al.
Pageof 3

Showing results (11-20 of 26) with videos related to

Sort By:
Pageof 3
The Journal of Reproductive Medicine|July 1, 1988
Concurrence of ovarian cancer and dermatomyositis. A report of two cases and literature reviewN Mordel, E J Margalioth, N Harats, et al.
International Journal of Oral and Maxillofacial Surgery|June 1, 1990
The use of monoclonal anti-CEA antibody immunohistochemistry in detecting the origin of oral cavity metastasisD W Nitzan, N Livni, Y Marmary, et al.
Investigational New Drugs|February 1, 1993
Phase II study of fazarabine (NSC 281272) in patients with metastatic colon cancerN Ben-Baruch, A M Denicoff, B R Goldspiel, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|October 1, 1990
Radiation therapy for locally advanced breast cancer: prognostic factors and complication rateZ Weshler, G Brufman, A Sulkes, et al.
Journal of Chemotherapy (Florence, Italy)|April 1, 1989
Methylprednisolone and chlorpromazine in patients receiving cancer chemotherapy: a prospective non-randomized studyE Gez, G Brufman, B Kaufman, et al.
Chemioterapia : International Journal of the Mediterranean Society of Chemotherapy|June 1, 1987
Combined immunotherapy and chemotherapy with tuftsin plus cyclophosphamide in the treatment of non-small-cell carcinoma of the lungE Warner, A Sulkes, E Gez, et al.
Cancer Research|February 25, 1990
Phase I and pharmacokinetic study of arabinofuranosyl-5-azacytosine (fazarabine, NSC 281272)A Surbone, H Ford, J A Kelley, et al.
Molecular Pharmacology|July 1, 1994
c-myc Down-regulation in suramin-treated HL60 cells precedes growth inhibition but does not trigger differentiationN Ben-Baruch, W C Reinhold, N Alexandrova, et al.
Oncology|January 1, 1987
High-dose metoclopramide and dexamethasone as an antiemetic in outpatients receiving chemotherapy for breast cancer. Second studyE Gez, E Warner-Efraty, R Ben-Yosef, et al.
European Journal of Cancer & Clinical Oncology|December 1, 1989
Systemic administration of doxorubicin-containing liposomes in cancer patients: a phase I studyA Gabizon, T Peretz, A Sulkes, et al.
Pageof 3